SH ALV-B NO

Therapeutic feline and canine cancer vaccine

Here we learn from Biljana Stangeland, PhD, Executive Director, Chief Scientific Officer and Co-founder at Alv B AS, about exciting new developments in therapeutic feline and canine cancer vaccine.

No posts to display

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders